Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 60 entries
Sorted by: Best Match Show Resources per page
Spatial Rogue Waves in Photorefractive Ferroelectrics.

Physical review letters

Pierangeli D, Di Mei F, Conti C, Agranat AJ, DelRe E.
PMID: 26371654
Phys Rev Lett. 2015 Aug 28;115(9):093901. doi: 10.1103/PhysRevLett.115.093901. Epub 2015 Aug 25.

Rogue waves are observed as light propagates in the extreme nonlinear regime that occurs when a photorefractive ferroelectric crystal is undergoing a structural phase transition. The transmitted spatial light distribution contains bright localized spots of anomalously large intensity that...

Cite
Pierangeli D, Di Mei F, Conti C, et al. Spatial Rogue Waves in Photorefractive Ferroelectrics. Phys Rev Lett. 2015;115(9):093901doi: 10.1103/PhysRevLett.115.093901.
Pierangeli, D., Di Mei, F., Conti, C., Agranat, A. J., & DelRe, E. (2015). Spatial Rogue Waves in Photorefractive Ferroelectrics. Physical review letters, 115(9), 093901. https://doi.org/10.1103/PhysRevLett.115.093901
Pierangeli, D, et al. "Spatial Rogue Waves in Photorefractive Ferroelectrics." Physical review letters vol. 115,9 (2015): 093901. doi: https://doi.org/10.1103/PhysRevLett.115.093901
Pierangeli D, Di Mei F, Conti C, Agranat AJ, DelRe E. Spatial Rogue Waves in Photorefractive Ferroelectrics. Phys Rev Lett. 2015 Aug 28;115(9):093901. doi: 10.1103/PhysRevLett.115.093901. Epub 2015 Aug 25. PMID: 26371654.
Copy Download .nbib Format: NLM
Pathophysiology of the antiphospholipid antibody syndrome.

Auto- immunity highlights

Willis R, Pierangeli SS.
PMID: 26000118
Auto Immun Highlights. 2011 Mar 24;2(2):35-52. doi: 10.1007/s13317-011-0017-9. eCollection 2011 Nov.

Antiphospholipid antibodies (aPL) are associated with the recurrent pregnancy loss and thrombosis that characterizes the antiphospholipid antibody syndrome (APS). Although the ontogeny of these pathogenic antibodies has not been fully elucidated, there is evidence that indicates the involvement of...

Cite
Willis R, Pierangeli SS. Pathophysiology of the antiphospholipid antibody syndrome. Auto Immun Highlights. 2011;2(2):35-52doi: 10.1007/s13317-011-0017-9.
Willis, R., & Pierangeli, S. S. (2011). Pathophysiology of the antiphospholipid antibody syndrome. Auto- immunity highlights, 2(2), 35-52. https://doi.org/10.1007/s13317-011-0017-9
Willis, Rohan, and Pierangeli, Silvia S. "Pathophysiology of the antiphospholipid antibody syndrome." Auto- immunity highlights vol. 2,2 (2011): 35-52. doi: https://doi.org/10.1007/s13317-011-0017-9
Willis R, Pierangeli SS. Pathophysiology of the antiphospholipid antibody syndrome. Auto Immun Highlights. 2011 Mar 24;2(2):35-52. doi: 10.1007/s13317-011-0017-9. eCollection 2011 Nov. PMID: 26000118; PMCID: PMC4389016.
Copy Download .nbib Format: NLM
Infliximab in the treatment of Crohn's disease.

Therapeutics and clinical risk management

Poggioli G, Laureti S, Campieri M, Pierangeli F, Gionchetti P, Ugolini F, Gentilini L, Bazzi P, Rizzello F, Coscia M.
PMID: 18360638
Ther Clin Risk Manag. 2007 Jun;3(2):301-8. doi: 10.2147/tcrm.2007.3.2.301.

The recent introduction of infliximab, a chimeric monoclonal antibody against tumor necrosis factor-alpha, has greatly modified the treatment of Crohn's disease (CD). Data from the literature show encouraging results after intravenous infusion both for closure of intestinal or perianal...

Cite
Poggioli G, Laureti S, Campieri M, et al. Infliximab in the treatment of Crohn's disease. Ther Clin Risk Manag. 2007;3(2):301-8doi: 10.2147/tcrm.2007.3.2.301.
Poggioli, G., Laureti, S., Campieri, M., Pierangeli, F., Gionchetti, P., Ugolini, F., Gentilini, L., Bazzi, P., Rizzello, F., & Coscia, M. (2007). Infliximab in the treatment of Crohn's disease. Therapeutics and clinical risk management, 3(2), 301-8. https://doi.org/10.2147/tcrm.2007.3.2.301
Poggioli, Gilberto, et al. "Infliximab in the treatment of Crohn's disease." Therapeutics and clinical risk management vol. 3,2 (2007): 301-8. doi: https://doi.org/10.2147/tcrm.2007.3.2.301
Poggioli G, Laureti S, Campieri M, Pierangeli F, Gionchetti P, Ugolini F, Gentilini L, Bazzi P, Rizzello F, Coscia M. Infliximab in the treatment of Crohn's disease. Ther Clin Risk Manag. 2007 Jun;3(2):301-8. doi: 10.2147/tcrm.2007.3.2.301. PMID: 18360638; PMCID: PMC1936311.
Copy Download .nbib Format: NLM
Novel therapies for the antiphospholipid syndrome.

Expert review of clinical immunology

Pierangeli SS.
PMID: 20477050
Expert Rev Clin Immunol. 2008 Mar;4(2):193-203. doi: 10.1586/1744666X.4.2.193.

Antiphospholipid antibodies (aPL Abs) are associated with thrombosis in patients with the antiphospholipid syndrome (APS). There is strong evidence that aPL Abs are pathogenic in vivo from studies in animal models. Furthermore, there are now convincing data indicating that...

Cite
Pierangeli SS. Novel therapies for the antiphospholipid syndrome. Expert Rev Clin Immunol. 2008;4(2):193-203doi: 10.1586/1744666X.4.2.193.
Pierangeli, S. S. (2008). Novel therapies for the antiphospholipid syndrome. Expert review of clinical immunology, 4(2), 193-203. https://doi.org/10.1586/1744666X.4.2.193
Pierangeli, Silvia S. "Novel therapies for the antiphospholipid syndrome." Expert review of clinical immunology vol. 4,2 (2008): 193-203. doi: https://doi.org/10.1586/1744666X.4.2.193
Pierangeli SS. Novel therapies for the antiphospholipid syndrome. Expert Rev Clin Immunol. 2008 Mar;4(2):193-203. doi: 10.1586/1744666X.4.2.193. PMID: 20477050.
Copy Download .nbib Format: NLM
Volume integrated phase modulator based on funnel waveguides for reconfigurable miniaturized optical circuits.

Optics letters

Parravicini J, Martínez Lorente R, Di Mei F, Pierangeli D, Agranat AJ, DelRe E.
PMID: 25831339
Opt Lett. 2015 Apr 01;40(7):1386-9. doi: 10.1364/OL.40.001386.

We demonstrate the integration of a miniaturized 30(x)  μm×30(y)  μm×2.7(z)  mm electro-optic phase modulator operating in the near-IR (λ=980  nm) based on the electro-activation of a funnel waveguide inside a paraelectric sample of photorefractive potassium lithium tantalate niobate. The...

Cite
Parravicini J, Martínez Lorente R, Di Mei F, et al. Volume integrated phase modulator based on funnel waveguides for reconfigurable miniaturized optical circuits. Opt Lett. 2015;40(7):1386-9doi: 10.1364/OL.40.001386.
Parravicini, J., Martínez Lorente, R., Di Mei, F., Pierangeli, D., Agranat, A. J., & DelRe, E. (2015). Volume integrated phase modulator based on funnel waveguides for reconfigurable miniaturized optical circuits. Optics letters, 40(7), 1386-9. https://doi.org/10.1364/OL.40.001386
Parravicini, J, et al. "Volume integrated phase modulator based on funnel waveguides for reconfigurable miniaturized optical circuits." Optics letters vol. 40,7 (2015): 1386-9. doi: https://doi.org/10.1364/OL.40.001386
Parravicini J, Martínez Lorente R, Di Mei F, Pierangeli D, Agranat AJ, DelRe E. Volume integrated phase modulator based on funnel waveguides for reconfigurable miniaturized optical circuits. Opt Lett. 2015 Apr 01;40(7):1386-9. doi: 10.1364/OL.40.001386. PMID: 25831339.
Copy Download .nbib Format: NLM
P063. Colloid cysts of the third ventricle: a case report.

The journal of headache and pain

de Pasqua S, Favoni V, Giannini G, Terlizzi R, Pierangeli G, Cortelli P, Cevoli S.
PMID: 28132257
J Headache Pain. 2015 Dec;16:A131. doi: 10.1186/1129-2377-16-S1-A131.

No abstract available.

Cite
de Pasqua S, Favoni V, Giannini G, et al. P063. Colloid cysts of the third ventricle: a case report. J Headache Pain. 2015;16:A131doi: 10.1186/1129-2377-16-S1-A131.
de Pasqua, S., Favoni, V., Giannini, G., Terlizzi, R., Pierangeli, G., Cortelli, P., & Cevoli, S. (2015). P063. Colloid cysts of the third ventricle: a case report. The journal of headache and pain, 16A131. https://doi.org/10.1186/1129-2377-16-S1-A131
de Pasqua, Silvia, et al. "P063. Colloid cysts of the third ventricle: a case report." The journal of headache and pain vol. 16 (2015): A131. doi: https://doi.org/10.1186/1129-2377-16-S1-A131
de Pasqua S, Favoni V, Giannini G, Terlizzi R, Pierangeli G, Cortelli P, Cevoli S. P063. Colloid cysts of the third ventricle: a case report. J Headache Pain. 2015 Dec;16:A131. doi: 10.1186/1129-2377-16-S1-A131. PMID: 28132257; PMCID: PMC4759087.
Copy Download .nbib Format: NLM
Genomics and epigenomics.

The journal of headache and pain

Garagnani P, Terlizzi R, Cevoli S, Capellari S, Pierangeli G, Pirazzini C, Bacalini MG, Franceschi C, Cortelli P.
PMID: 28132381
J Headache Pain. 2015 Dec;16:A7. doi: 10.1186/1129-2377-16-S1-A7.

No abstract available.

Cite
Garagnani P, Terlizzi R, Cevoli S, et al. Genomics and epigenomics. J Headache Pain. 2015;16:A7doi: 10.1186/1129-2377-16-S1-A7.
Garagnani, P., Terlizzi, R., Cevoli, S., Capellari, S., Pierangeli, G., Pirazzini, C., Bacalini, M. G., Franceschi, C., & Cortelli, P. (2015). Genomics and epigenomics. The journal of headache and pain, 16A7. https://doi.org/10.1186/1129-2377-16-S1-A7
Garagnani, Paolo, et al. "Genomics and epigenomics." The journal of headache and pain vol. 16 (2015): A7. doi: https://doi.org/10.1186/1129-2377-16-S1-A7
Garagnani P, Terlizzi R, Cevoli S, Capellari S, Pierangeli G, Pirazzini C, Bacalini MG, Franceschi C, Cortelli P. Genomics and epigenomics. J Headache Pain. 2015 Dec;16:A7. doi: 10.1186/1129-2377-16-S1-A7. PMID: 28132381; PMCID: PMC4759335.
Copy Download .nbib Format: NLM
Intrinsic Negative Mass from Nonlinearity.

Physical review letters

Di Mei F, Caramazza P, Pierangeli D, Di Domenico G, Ilan H, Agranat AJ, Di Porto P, DelRe E.
PMID: 27127969
Phys Rev Lett. 2016 Apr 15;116(15):153902. doi: 10.1103/PhysRevLett.116.153902. Epub 2016 Apr 14.

We propose and provide experimental evidence of a mechanism able to support negative intrinsic effective mass. The idea is to use a shape-sensitive nonlinearity to change the sign of the mass in the leading linear propagation equation. Intrinsic negative-mass...

Cite
Di Mei F, Caramazza P, Pierangeli D, et al. Intrinsic Negative Mass from Nonlinearity. Phys Rev Lett. 2016;116(15):153902doi: 10.1103/PhysRevLett.116.153902.
Di Mei, F., Caramazza, P., Pierangeli, D., Di Domenico, G., Ilan, H., Agranat, A. J., Di Porto, P., & DelRe, E. (2016). Intrinsic Negative Mass from Nonlinearity. Physical review letters, 116(15), 153902. https://doi.org/10.1103/PhysRevLett.116.153902
Di Mei, F, et al. "Intrinsic Negative Mass from Nonlinearity." Physical review letters vol. 116,15 (2016): 153902. doi: https://doi.org/10.1103/PhysRevLett.116.153902
Di Mei F, Caramazza P, Pierangeli D, Di Domenico G, Ilan H, Agranat AJ, Di Porto P, DelRe E. Intrinsic Negative Mass from Nonlinearity. Phys Rev Lett. 2016 Apr 15;116(15):153902. doi: 10.1103/PhysRevLett.116.153902. Epub 2016 Apr 14. PMID: 27127969.
Copy Download .nbib Format: NLM
Topological control of extreme waves.

Nature communications

Marcucci G, Pierangeli D, Agranat AJ, Lee RK, DelRe E, Conti C.
PMID: 31704911
Nat Commun. 2019 Nov 08;10(1):5090. doi: 10.1038/s41467-019-12815-0.

From optics to hydrodynamics, shock and rogue waves are widespread. Although they appear as distinct phenomena, transitions between extreme waves are allowed. However, these have never been experimentally observed because control strategies are still missing. We introduce the new...

Cite
Marcucci G, Pierangeli D, Agranat AJ, et al. Topological control of extreme waves. Nat Commun. 2019;10(1):5090doi: 10.1038/s41467-019-12815-0.
Marcucci, G., Pierangeli, D., Agranat, A. J., Lee, R. K., DelRe, E., & Conti, C. (2019). Topological control of extreme waves. Nature communications, 10(1), 5090. https://doi.org/10.1038/s41467-019-12815-0
Marcucci, Giulia, et al. "Topological control of extreme waves." Nature communications vol. 10,1 (2019): 5090. doi: https://doi.org/10.1038/s41467-019-12815-0
Marcucci G, Pierangeli D, Agranat AJ, Lee RK, DelRe E, Conti C. Topological control of extreme waves. Nat Commun. 2019 Nov 08;10(1):5090. doi: 10.1038/s41467-019-12815-0. PMID: 31704911; PMCID: PMC6841676.
Copy Download .nbib Format: NLM
Anomalous interaction of Airy beams in the fractional nonlinear Schrödinger equation.

Optics express

Zhang L, Zhang X, Wu H, Li C, Pierangeli D, Gao Y, Fan D.
PMID: 31684555
Opt Express. 2019 Sep 30;27(20):27936-27945. doi: 10.1364/OE.27.027936.

We investigate the mutual interaction of two spatially-separated Airy beams in the nonlinear Schrödinger equation with the fractional Laplacian. Depending on the beam separation (

Cite
Zhang L, Zhang X, Wu H, et al. Anomalous interaction of Airy beams in the fractional nonlinear Schrödinger equation. Opt Express. 2019;27(20):27936-27945doi: 10.1364/OE.27.027936.
Zhang, L., Zhang, X., Wu, H., Li, C., Pierangeli, D., Gao, Y., & Fan, D. (2019). Anomalous interaction of Airy beams in the fractional nonlinear Schrödinger equation. Optics express, 27(20), 27936-27945. https://doi.org/10.1364/OE.27.027936
Zhang, Lifu, et al. "Anomalous interaction of Airy beams in the fractional nonlinear Schrödinger equation." Optics express vol. 27,20 (2019): 27936-27945. doi: https://doi.org/10.1364/OE.27.027936
Zhang L, Zhang X, Wu H, Li C, Pierangeli D, Gao Y, Fan D. Anomalous interaction of Airy beams in the fractional nonlinear Schrödinger equation. Opt Express. 2019 Sep 30;27(20):27936-27945. doi: 10.1364/OE.27.027936. PMID: 31684555.
Copy Download .nbib Format: NLM
A Randomized Clinical Trial on Acupuncture Versus Best Medical Therapy in Episodic Migraine Prophylaxis: The ACUMIGRAN Study.

Frontiers in neurology

Giannini G, Favoni V, Merli E, Nicodemo M, Torelli P, Matrà A, Giovanardi CM, Cortelli P, Pierangeli G, Cevoli S.
PMID: 33519664
Front Neurol. 2021 Jan 15;11:570335. doi: 10.3389/fneur.2020.570335. eCollection 2020.

No abstract available.

Cite
Giannini G, Favoni V, Merli E, et al. A Randomized Clinical Trial on Acupuncture Versus Best Medical Therapy in Episodic Migraine Prophylaxis: The ACUMIGRAN Study. Front Neurol. 2021;11:570335doi: 10.3389/fneur.2020.570335.
Giannini, G., Favoni, V., Merli, E., Nicodemo, M., Torelli, P., Matrà, A., Giovanardi, C. M., Cortelli, P., Pierangeli, G., & Cevoli, S. (2020). A Randomized Clinical Trial on Acupuncture Versus Best Medical Therapy in Episodic Migraine Prophylaxis: The ACUMIGRAN Study. Frontiers in neurology, 11570335. https://doi.org/10.3389/fneur.2020.570335
Giannini, Giulia, et al. "A Randomized Clinical Trial on Acupuncture Versus Best Medical Therapy in Episodic Migraine Prophylaxis: The ACUMIGRAN Study." Frontiers in neurology vol. 11 (2020): 570335. doi: https://doi.org/10.3389/fneur.2020.570335
Giannini G, Favoni V, Merli E, Nicodemo M, Torelli P, Matrà A, Giovanardi CM, Cortelli P, Pierangeli G, Cevoli S. A Randomized Clinical Trial on Acupuncture Versus Best Medical Therapy in Episodic Migraine Prophylaxis: The ACUMIGRAN Study. Front Neurol. 2021 Jan 15;11:570335. doi: 10.3389/fneur.2020.570335. eCollection 2020. PMID: 33519664; PMCID: PMC7843562.
Copy Download .nbib Format: NLM
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients.

Microorganisms

Bitossi C, Frasca F, Viscido A, Oliveto G, Scordio M, Belloni L, Cimino G, Pietropaolo V, Gentile M, d'Ettorre G, Midulla F, Trancassini M, Antonelli G, Pierangeli A, Scagnolari C.
PMID: 33401565
Microorganisms. 2021 Jan 03;9(1). doi: 10.3390/microorganisms9010093.

The expression rate of SARS-CoV-2 entry genes, angiotensin-converting enzyme 2 (ACE2), the main viral receptor and the proteases, furin and transmembrane serine protease 2 (TMPRSS2) in cystic fibrosis (CF) individuals is poorly known. Hence, we examined their levels in...

Cite
Bitossi C, Frasca F, Viscido A, et al. SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients. Microorganisms. 2021;9(1)doi: 10.3390/microorganisms9010093.
Bitossi, C., Frasca, F., Viscido, A., Oliveto, G., Scordio, M., Belloni, L., Cimino, G., Pietropaolo, V., Gentile, M., d'Ettorre, G., Midulla, F., Trancassini, M., Antonelli, G., Pierangeli, A., & Scagnolari, C. (2021). SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients. Microorganisms, 9(1), . https://doi.org/10.3390/microorganisms9010093
Bitossi, Camilla, et al. "SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients." Microorganisms vol. 9,1 (2021). doi: https://doi.org/10.3390/microorganisms9010093
Bitossi C, Frasca F, Viscido A, Oliveto G, Scordio M, Belloni L, Cimino G, Pietropaolo V, Gentile M, d'Ettorre G, Midulla F, Trancassini M, Antonelli G, Pierangeli A, Scagnolari C. SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients. Microorganisms. 2021 Jan 03;9(1). doi: 10.3390/microorganisms9010093. PMID: 33401565; PMCID: PMC7824643.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 60 entries